

Cover Story
The caveats should be acknowledged: Yes, all cancer centers are different. If you've seen one, you've seen one. Yes, every center director has a different political and economic situation on his or her hands, and, sure, the observation that follows in the next paragraph could well be a fluke:
By Matthew Bin Han Ong
In Brief


Trending Stories
- Imaging’s ride to the bottom in clinical trials—and why it matters now
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - In the Headlines: Is oncology ready to move away from animal testing?
- NIH says it’s moving away from animal-based models
- The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic - ODAC nixes GSK’s Blenrep myeloma regimens, citing ocular toxicity, dosing, applicability to U.S. population